Pages that link to "Q40614262"

The following pages link to Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens (Q40614262):

Displaying 41 items.

• The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis (Q24622720) (← links)
• Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population (Q24651401) (← links)
• Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo (Q24797399) (← links)
• Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA (Q27011221) (← links)
• Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. (Q30438632) (← links)
• Pathways to tamoxifen resistance (Q30441001) (← links)
• New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death (Q33354763) (← links)
• Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction (Q33531646) (← links)
• Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway (Q33583914) (← links)
• Letrozole: a review of its use in postmenopausal women with breast cancer (Q34322778) (← links)
• Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors (Q34363866) (← links)
• Apoptosis and autophagy in breast cancer cells following exemestane treatment (Q34388747) (← links)
• DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer. (Q34484781) (← links)
• MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer (Q34984068) (← links)
• Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients (Q34998421) (← links)
• Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). (Q35111066) (← links)
• Tamoxifen non-estrogen receptor mediated molecular targets (Q35569331) (← links)
• Cell death signaling and anticancer therapy (Q35972102) (← links)
• Zoledronic acid inhibits aromatase activity and phosphorylation: Potential mechanism for additive zoledronic acid and letrozole drug interaction (Q36295928) (← links)
• Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer (Q36331426) (← links)
• Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis (Q36643119) (← links)
• Stopping treatment can reverse acquired resistance to letrozole (Q36800183) (← links)
• The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis (Q36881741) (← links)
• Estrogenic or antiestrogenic therapies for multiple myeloma? (Q36948728) (← links)
• The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer (Q36955067) (← links)
• Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro. (Q37284410) (← links)
• CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen (Q37386840) (← links)
• Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells (Q37440551) (← links)
• Antiproliferative effect of exemestane in lung cancer cells (Q37460552) (← links)
• Letrozole: a review of its use in the treatment of postmenopausal women with hormone-responsive early breast cancer (Q37579185) (← links)
• Synthesis and Spectroscopic and Biological Activities of Zn(II) Porphyrin with Oxygen Donors (Q37686663) (← links)
• Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? (Q38028797) (← links)
• Thymoquinone Could Increase The Efficacy of Tamoxifen Induced Apoptosis in Human Breast Cancer Cells: An In Vitro Study. (Q39474431) (← links)
• Synthesis, Spectroscopic, and Biological Studies on New Zirconium(IV) Porphyrins with Axial Ligand (Q41835622) (← links)
• Synthesis and Spectroscopic Characterization of Some New Axially Ligated Indium(III) Macrocyclic Complexes and Their Biological Activities. (Q41988438) (← links)
• A Five-Gene Model Predicts Clinical Outcome in ER+/PR+, Early-Stage Breast Cancers Treated with Adjuvant Tamoxifen (Q44811677) (← links)
• Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation (Q51437937) (← links)
• Induction of apoptosis and downregulation of ERα in DMBA-induced mammary gland tumors in Sprague-Dawley rats by synthetic 3,5-disubstituted isoxazole derivatives (Q51606667) (← links)
• BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients. (Q54298525) (← links)
• Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer (Q90401748) (← links)
• Synthesis and bioactivity of oxovanadium(IV)tetra(4-methoxyphenyl)porphyrinsalicylates (Q92437651) (← links)